Clinical medications development for opiate addiction: Focus on nonopioids and opioid antagonists for the amelioration of opiate withdrawal symptoms and relapse prevention

被引：23
作者：
Herman, BH
O'Brien, CP
机构：
[1] NIDA, Clin Trials Branch, Medicat Dev Div, NIH, Rockville, MD 20857 USA
[2] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
来源：
SEMINARS IN NEUROSCIENCE | 1997年 / 9卷 / 3-4期
关键词：
D O I：
10.1006/smns.1997.0115
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 172
页数：15
相关论文
共 125 条
[1]  
ACETO MD, 1992, NIDA RES MONOGR, V119, P554
[2]  
AGHAJANIAN GK, 1982, J CLIN PSYCHIAT, V43, P20
[3]  
[Anonymous], 1978, Arch Gen Psychiatry, V35, P335
[4]  
ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287
[5]  
ASTONJONES G, 1993, NEUROBIOLOGY OPIATES, P175
[6]  
AUER RN, 1994, ACTA NEUROPATHOL, V87, P1
[7]  
Ball J.C., 1991, EFFECTIVENESS METHAD
[8]  
BALSTER R L, 1990, Journal of Clinical Psychopharmacology, V10, p31S
[9]  
BARBER NS, 1989, PAIN, V39, P307
[10]   DURATION OF ANTAGONISTIC EFFECTS OF NALMEFENE AND NALOXONE IN OPIATE-INDUCED SEDATION FOR EMERGENCY DEPARTMENT PROCEDURES [J].
BARSAN, WG ;
SEGER, D ;
DANZL, DF ;
LING, LJ ;
BARTLETT, R ;
BUNCHER, R ;
BRYAN, C .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1989, 7 (02) :155-161
12345678910